Literature DB >> 17947747

Ototoxicity caused by aminoglycosides.

Maria Bitner-Glindzicz, Shamima Rahman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17947747      PMCID： PMC2034737          DOI： 10.1136/bmj.39301.680266.AE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Rapid identification of an A1555G mutation in human mitochondrial DNA implicated in aminoglycoside-induced ototoxicity.

Authors:  B J Scrimshaw; J M Faed; W P Tate; K Yun
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

2.  The societal costs of severe to profound hearing loss in the United States.

Authors:  P E Mohr; J J Feldman; J L Dunbar
Journal:  Policy Anal Brief H Ser       Date:  2000-04

3.  Genetic aspects of antibiotic induced deafness: mitochondrial inheritance.

Authors:  D N Hu; W Q Qui; B T Wu; L Z Fang; F Zhou; Y P Gu; Q H Zhang; J H Yan; Y Q Ding; H Wong
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

4.  Prevalence of mitochondrial gene mutations among hearing impaired patients.

Authors:  S Usami; S Abe; J Akita; A Namba; H Shinkawa; M Ishii; S Iwasaki; T Hoshino; J Ito; K Doi; T Kubo; T Nakagawa; S Komiyama; T Tono; S Komune
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

5.  Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations.

Authors:  Min-Xin Guan; Qingfeng Yan; Xiaoming Li; Yelena Bykhovskaya; Jaime Gallo-Teran; Petr Hajek; Noriko Umeda; Hui Zhao; Gema Garrido; Emebet Mengesha; Tsutomu Suzuki; Ignacio del Castillo; Jennifer Lynne Peters; Ronghua Li; Yaping Qian; Xinjian Wang; Ester Ballana; Mordechai Shohat; Jianxin Lu; Xavier Estivill; Kimitsuna Watanabe; Nathan Fischel-Ghodsian
Journal:  Am J Hum Genet       Date:  2006-06-22       Impact factor: 11.025

6.  The incidence of aminoglycoside antibiotic-induced hearing loss.

Authors:  R E Brummett; R B Morrison
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-04

7.  Health-service costs of pediatric cochlear implantation: multi-center analysis.

Authors:  Garry R Barton; Karen E Bloor; David H Marshall; A Quentin Summerfield
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-02       Impact factor: 1.675

8.  Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment.

Authors:  T P Hutchin; K R Thompson; M Parker; V Newton; M Bitner-Glindzicz; R F Mueller
Journal:  J Med Genet       Date:  2001-04       Impact factor: 6.318

9.  Very low penetrance of hearing loss in seven Han Chinese pedigrees carrying the deafness-associated 12S rRNA A1555G mutation.

Authors:  Xiaowen Tang; Li Yang; Yi Zhu; Zhisu Liao; Jindan Wang; Yaping Qian; Zhihua Tao; Lenong Hu; Guomin Wu; Jinshan Lan; Xinjian Wang; Jingzhang Ji; Jian Wu; Yu Ji; Jinbao Feng; Jianfu Chen; Zhiyuan Li; Xue Zhang; Jianxin Lu; Min-Xin Guan
Journal:  Gene       Date:  2007-01-24       Impact factor: 3.688

10.  Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?

Authors:  Hsiao-Yuan Tang; Eldridge Hutcheson; Susan Neill; Margaret Drummond-Borg; Michael Speer; Raye Lynn Alford
Journal:  Genet Med       Date:  2002 Sep-Oct       Impact factor: 8.822
View more
  18 in total

1.  Aminoglycoside ototoxicity: Vestibular function is also vulnerable.

Authors:  Barry M Seemungal; Adolfo M Bronstein
Journal:  BMJ       Date:  2007-11-10

2.  Aminoglycoside ototoxicity: How practical is this genetic screening test?

Authors:  Thomas Rourke
Journal:  BMJ       Date:  2007-11-10

3.  Genetic testing in the acute setting: a round table discussion.

Authors:  John Henry McDermott
Journal:  J Med Ethics       Date:  2020-07-10       Impact factor: 2.903

Review 4.  Common Aminoglycosides and Platinum-Based Ototoxic Drugs: Cochlear/Vestibular Side Effects and Incidence.

Authors:  Robert M DiSogra
Journal:  Semin Hear       Date:  2019-04-26

Review 5.  Nervous system effects of antituberculosis therapy.

Authors:  Joseph S Kass; Wayne X Shandera
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 6.  Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group.

Authors:  Satkiran Grewal; Thomas Merchant; Renee Reymond; Maryrose McInerney; Cathy Hodge; Patricia Shearer
Journal:  Pediatrics       Date:  2010-03-01       Impact factor: 7.124

7.  Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells.

Authors:  Makoto Kamei; Karissa Kasperski; Maria Fuller; Emma J Parkinson-Lawrence; Litsa Karageorgos; Valery Belakhov; Timor Baasov; John J Hopwood; Doug A Brooks
Journal:  JIMD Rep       Date:  2013-11-06

8.  Susceptibility genes for gentamicin-induced vestibular dysfunction.

Authors:  Stephen M Roth; Scott M Williams; Lan Jiang; Kalapurakkal S Menon; John J Jeka
Journal:  J Vestib Res       Date:  2008       Impact factor: 2.435

9.  Hearing in 44-45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study.

Authors:  Shamima Rahman; Russell Ecob; Harry Costello; Mary G Sweeney; Andrew J Duncan; Kerra Pearce; David Strachan; Andrew Forge; Adrian Davis; Maria Bitner-Glindzicz
Journal:  BMJ Open       Date:  2012-01-05       Impact factor: 2.692

10.  Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial.

Authors:  John Henry McDermott; Rachel Mahood; Duncan Stoddard; Ajit Mahaveer; Mark A Turner; Rachel Corry; Julia Garlick; Gino Miele; Shaun Ainsworth; Laura Kemp; Iain Bruce; Richard Body; Fiona Ulph; Rhona Macleod; Karen Harvey; Nicola Booth; Peter Roberts; Paul Wilson; William G Newman
Journal:  BMJ Open       Date:  2021-06-16       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.